EarningsQ4 2024 Earnings Report

Loews (L) Q4 2024 Earnings Report

1 Followers

Previous Report: Q3 2024

Next Report: Q1 2025

MX:L Q4 2024 EPS Results

Actual EPS$40.55

Consensus EPS―

Beat/Miss―

One Year Ago EPS$34.29

MX:L Q4 2024 Revenue Results

Actual Revenue$78.69B

Expected Revenue―

Beat/Miss―

YoY Revenue Growth+6.76%

Earnings Announcement Details

QuarterQ4 2024

Date02/10/2025

TimeBefore Open

Conference CallMonday, February 10, 2025

MX:L Upcoming Earnings

Loews's next earnings date is estimated for November 2, 2026, based on past reporting schedules.

Q4 2024 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2024 Earnings Slide Deck

Q4 2024 Earnings Call Summary

Q4 2024

Earnings Call Date:Feb 10, 2025|

% Change Since:

Earnings Call Sentiment|Positive

The earnings call presented a strong financial performance with significant revenue and market share growth, supported by strategic expansions and digital sales gains. However, there were challenges such as decreased GAAP net earnings due to a non-cash charge, impacts from the Canada Post strike, vendor price increases, currency fluctuations, and a strategic exit from the electronics category. Overall, the positives slightly outweigh the negatives, indicating a positive sentiment.

Company Guidance

In the fourth quarter of 2024, Loblaws Incorporated reported strong financial performance, with full-year revenue reaching $61 billion and adjusted earnings surpassing $2.6 billion. The company achieved a 2.9% increase in consolidated revenue for the quarter, totaling $14.9 billion, while adjusted EBITDA grew by 4%. Adjusted diluted net earnings per share rose by 10% to $2.20, although GAAP net earnings decreased by 14.6% due to a $129 million non-cash charge related to the PC Optimum program. Loblaws repurchased $1.8 billion worth of shares and increased its dividend per share by 13.9%. The company also expanded its retail footprint by adding 52 new food and drug retail stores and 78 pharmacy care clinics, representing a 1.1% increase in square footage. Looking ahead, Loblaws plans to invest over $10 billion in the Canadian economy over the next five years, including opening 80 new stores and approximately 100 pharmacist care clinics in 2025. Despite challenges such as inflationary pressures and a declining Canadian dollar, the company anticipates high single-digit growth in adjusted earnings per share for 2025, bolstered by an additional fiscal week and continued investment in its retail and distribution networks.

Record Revenue and Earnings Growth

Loblaws reported full-year revenue of $61 billion and adjusted earnings of over $2.6 billion. Adjusted diluted net earnings per share grew by 10% to $2.20.

Expansion and Investment Plan

Loblaws plans to reinvest over $10 billion into the Canadian economy over the next five years, including opening another 80 stores and approximately 100 pharmacist care clinics in 2025.

Market Share and Sales Growth

Loblaws reported its best full-year food market share growth in more than a decade, with absolute sales growth of 3.7% and same-store sales increasing by 2.5%.

Strong Digital Sales Performance

Online sales increased by 18.4% in the quarter, with full-year sales growing by 16.9% to $3.9 billion.

Successful New Store Openings

Loblaws opened 26 new grocery stores in Q4, including its first TNT supermarket in Seattle, Washington, and concluded its network optimization initiative in Quebec.

MX:L Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 02, 2026	2026 (Q3)	- / -	45.228	―
Aug 03, 2026	2026 (Q2)	- / 39.91	37.404	6.71% (+2.51)
May 04, 2026	2026 (Q1)	- / 30.81	32.471	-5.12% (-1.66)
Feb 09, 2026	2025 (Q4)	- / 37.01	40.555	-8.75% (-3.55)
Nov 03, 2025	2025 (Q3)	- / 45.23	33.943	33.25% (+11.29)
Aug 04, 2025	2025 (Q2)	- / 37.40	31.641	18.22% (+5.76)
May 05, 2025	2025 (Q1)	- / 32.47	35.016	-7.27% (-2.54)
Feb 10, 2025	2024 (Q4)	- / 40.55	34.289	18.27% (+6.27)
Nov 04, 2024	2024 (Q3)	- / 33.94	21.446	58.27% (+12.50)
Jul 29, 2024	2024 (Q2)	- / 31.64	31.364	0.88% (+0.28)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed